Posts for tag: Pharmaceutical
Now Offering Five Innovation Centers to Support R&D Operations for Innovative Companies Plymouth Meeting, PA, February 19, 2024 – Novita Equities, a PROTECS Company, has recently acquired a 35,155-square-foot research and development lab facility located within Bucks County, PA. PROTECS is proud to add this fifth innovation center to its existing portfolio of four innovation […]
Continuing to provide design-build services to the Southeast Region Plymouth Meeting, P.A. and Raleigh, N.C., May 19, 2023 – PROTECS, a leading full-service project and construction management company, is excited to relocate and expand its North Carolina office operations to better serve new and existing life sciences, contract manufacturing, high-tech, and semiconductor clients throughout the […]
SWAGGER MAGAZINE
December 8, 2022
PROTECS celebrates another important milestone for Purolite’s new pharmaceutical manufacturing facility.
Brings more than 18 years’ experience managing construction projects in the high-tech and life sciences markets Plymouth Meeting, PA and Raleigh, NC – November 29, 2022 – PROTECS, a leading full-service project and construction management company, is pleased to announce Marc Blackwelder’s promotion to Director of Operations, Southeast Region. Through its unique, collaborative and innovative […]
Continuing to provide project and construction management services to the Intermountain and West Coast through all project phases Plymouth Meeting, Penn. and Salt Lake City, Utah – November 18, 2022 – PROTECS relocates and grows its Utah office operations to better serve new and existing high-tech, life sciences, semiconductor, and food and nutraceutical clients in […]
March 16, 2021
Provides Leveraged Design/Build Services for Clients and Tenants During Challenging Times Plymouth Meeting, PA, March 16, 2021 – PROTECS is proud to highlight innovative life sciences companies who support the global fight against COVID-19 with integral diagnostic tests and customized clinical trial services. “I work as a joint head of new assay development, where I […]